For the first time, a drug has reduced deaths from severe sepsis, a life-threatening immune reaction occurring in 750,000 people in the United States each year.
Severe sepsis results from a person’s immune reaction, usually to a bloodborne infection. The current standard treatment for the illness includes antibiotics to fight the infection and intensive care to counter organ failure or very low blood pressure.
Log in
Subscribers, enter your e-mail address for full access to the Science News archives and digital editions.